The FDA has recently approved two generic versions of apixaban and from the amount of apixaban I’m s
Read More
Any compounds you use during drug discovery and development have started their journey long before t
Read More
The trends are clear: patients and institutions across the nation are concerned about skyrocketing d
Read More
Drug Target Review explores the latest applications of stem cells in modelling disease, drug product
Read More
For many industries, the thought of a post-Brexit world can be a fearful one; the repercussions are
Read More
Last month, Dr. Elizabeth O’Day of Waltham, MA-based precision medicine startup Olaris, Inc. was kin
Read More
Prices for drugs should reflect their value. If price and value become disconnected, efforts to prod
Read More